Citations are updated once a week. Recently added citations may not appear.
| Context | Citation |
|---|---|
| bacillus - Coprococcus comes |
👶
Effect of dietary supplementation with Lactobacillus acidophilus D2/CSL (CECT 4529) on caecum microbioma and productive performance in broiler chickens. PloS one (PLoS One ) Vol: 12 Issue 5 Pages: e0176309 Pub: 2017 Epub: 2017 May 4 Authors De Cesare A , Sirri F , Manfreda G , Moniaci P , Giardini A , Zampiga M , Meluzzi A , Html Article Publication |
| bacillus - Coprococcus comes |
👶
Dietary supplementation with Bacillus subtilis DSM 32315 alters the intestinal microbiota and metabolites in weaned piglets. Journal of applied microbiology (J Appl Microbiol ) Vol: Issue Pages: Pub: 2020 Jul 6 Epub: 2020 Jul 6 Authors Ding H , Zhao X , Ma C , Gao Q , Yin Y , Kong X , He J , Publication Publication |
| bacillus - Coprococcus comes |
👶
Bacillus pumilus and Bacillus subtilis Promote Early Maturation of Cecal Microbiota in Broiler Chickens. Microorganisms (Microorganisms ) Vol: 9 Issue 9 Pages: Pub: 2021 Sep 7 Epub: 2021 Sep 7 Authors Bilal M , Achard C , Barbe F , Chevaux E , Ronholm J , Zhao X , Publication |
| bacillus - Coprococcus comes |
👶
Effect of an Enteroprotective Complementary Feed on Faecal Markers of Inflammation and Intestinal Microbiota Composition in Weaning Puppies. Veterinary sciences (Vet Sci ) Vol: 10 Issue 7 Pages: Pub: 2023 Jul 3 Epub: 2023 Jul 3 Authors Meineri G , Cocolin L , Morelli G , Schievano C , Atuahene D , Ferrocino I , Publication |
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
